The Genxai Analytics IPO is a closed SME Bookbuilding offer (Fresh capital only) that opened on 5 June 2026. The Genxai Analytics IPO closed on 9 June 2026, with an issue price of ₹116 per share. The Genxai Analytics IPO has a face value of ₹10 and a lot size of 1,200 shares. The Genxai Analytics IPO is listed on 12 June 2026. The Genxai Analytics IPO allotment was scheduled for 10 June 2026.
On the financial front, the Genxai Analytics IPO reported revenue of ₹64 crore for 31 Dec 2025, compared with ₹29 crore for 31 Mar 2025. The Genxai Analytics IPO PAT was ₹13 crore against ₹7 crore. The Genxai Analytics IPO EBITDA stood at ₹19 crore with a 29.52% margin. The Genxai Analytics IPO net worth as of 31 Dec 2025 was ₹31 crore.
Always verify The Genxai Analytics IPO details and GMP data with the official offer document before investing in the Genxai Analytics IPO.
Financial Summary
Amount in ₹ Crore
Metric
31 Dec 2025
31 Mar 2025
31 Mar 2024
Total Assets
73
24
11
Revenue
64
29
24
PAT
13
7
3
EBITDA
19
10
4
Net Worth
31
11
4
Reserves
19
11
4
Total Borrowing
16
7
4
Genxai Analytics IPO Financials FAQs
Revenue of Genxai Analytics (Amount in ₹ Crore) — 31 Dec 2025: 64; 31 Mar 2025: 29; 31 Mar 2024: 24. Profit after tax (PAT) — 31 Dec 2025: 13; 31 Mar 2025: 7; 31 Mar 2024: 3.
EBITDA of Genxai Analytics (Amount in ₹ Crore) — 31 Dec 2025: 19; 31 Mar 2025: 10; 31 Mar 2024: 4. The EBITDA margin is 29.52%.
Total assets — 31 Dec 2025: 73; 31 Mar 2025: 24; 31 Mar 2024: 11. Net worth — 31 Dec 2025: 31; 31 Mar 2025: 11; 31 Mar 2024: 4. Reserves & surplus — 31 Dec 2025: 19; 31 Mar 2025: 11; 31 Mar 2024: 4. (Amount in ₹ Crore)
Total borrowing of Genxai Analytics (Amount in ₹ Crore) — 31 Dec 2025: 16; 31 Mar 2025: 7; 31 Mar 2024: 4. Debt-to-equity ratio: 0.52.
The financials shown for Genxai Analytics IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
